AR004488A1 - Un conjugado de polimixina, y sales solubles del mismo, proceso para producir dicho conjugado, composicion farmaceutica que incluye dicho conjugado y uso del mismo para la preparacion de medicamentos - Google Patents

Un conjugado de polimixina, y sales solubles del mismo, proceso para producir dicho conjugado, composicion farmaceutica que incluye dicho conjugado y uso del mismo para la preparacion de medicamentos

Info

Publication number
AR004488A1
AR004488A1 ARP960102707A AR10270796A AR004488A1 AR 004488 A1 AR004488 A1 AR 004488A1 AR P960102707 A ARP960102707 A AR P960102707A AR 10270796 A AR10270796 A AR 10270796A AR 004488 A1 AR004488 A1 AR 004488A1
Authority
AR
Argentina
Prior art keywords
conjugate
same
polymixine
medicines
preparation
Prior art date
Application number
ARP960102707A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR004488A1 publication Critical patent/AR004488A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invención se refiere a conjugados de polimixina B/dextrano o sales de los mismos, solubles en agua, que tienen una actividadantiendotoxínica o en contra de las endotoxinas, mayor que la de polimixina B no conjugada, útiles en eltrata miento profiláctico o curativo del síndrome derespuesta inflamatoria sistémica o choque séptico. Estos conjugados se pueden preparar mediante la reacción de la polimixina B o una sal de la misma, condextrano, en un medio acuoso a un pH desdeaproxi madamente 9,3 hasta aproximadamente 10, y a una temperatura desde aproximadamente 30°C hastaaproximadamente 35°C.
ARP960102707A 1995-05-25 1996-05-24 Un conjugado de polimixina, y sales solubles del mismo, proceso para producir dicho conjugado, composicion farmaceutica que incluye dicho conjugado y uso del mismo para la preparacion de medicamentos AR004488A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/449,436 US5691304A (en) 1995-05-25 1995-05-25 Improved process for preparing polymyxin B/dextran conjugates

Publications (1)

Publication Number Publication Date
AR004488A1 true AR004488A1 (es) 1998-12-16

Family

ID=23784156

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102707A AR004488A1 (es) 1995-05-25 1996-05-24 Un conjugado de polimixina, y sales solubles del mismo, proceso para producir dicho conjugado, composicion farmaceutica que incluye dicho conjugado y uso del mismo para la preparacion de medicamentos

Country Status (24)

Country Link
US (1) US5691304A (es)
EP (1) EP0830147A1 (es)
JP (1) JPH11505216A (es)
KR (1) KR19990021926A (es)
CN (1) CN1185115A (es)
AR (1) AR004488A1 (es)
AU (1) AU711200B2 (es)
BR (1) BR9609130A (es)
CA (1) CA2219778A1 (es)
CO (1) CO4700478A1 (es)
CZ (1) CZ288830B6 (es)
FI (1) FI974004A (es)
HU (1) HUP9801750A3 (es)
IL (1) IL118407A (es)
NO (1) NO975329D0 (es)
NZ (1) NZ309764A (es)
PE (1) PE5398A1 (es)
PL (1) PL323186A1 (es)
RU (1) RU2164149C2 (es)
SK (1) SK157997A3 (es)
TR (1) TR199701426T1 (es)
TW (1) TW426517B (es)
WO (1) WO1996037233A1 (es)
ZA (1) ZA964210B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2263164A1 (en) * 1996-08-15 1998-02-19 Southern Illinois University Enhancement of antimicrobial peptide activity by metal ions
US20080287633A1 (en) * 2007-05-18 2008-11-20 Drumheller Paul D Hydrogel Materials
US20180028684A1 (en) 2010-11-01 2018-02-01 Nanoderm Sciences, Inc. Targeted nanoparticles
US9161962B2 (en) 2010-11-01 2015-10-20 Nanoderm Sciences, Inc. Targeted therapeutic nanoparticles
EP2872120B1 (en) * 2012-07-16 2017-05-03 Nanoderm Sciences, Inc. Therapeutic nanoparticles with a polymyxin b as targeting agent
CN115321819B (zh) * 2022-08-15 2024-02-13 希诺股份有限公司 一种高钢化抗菌玻璃杯及其制造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2063326T3 (es) * 1989-11-15 1995-01-01 Sandoz Ltd Conjugados de polimixina.
US5177059A (en) * 1989-11-15 1993-01-05 Sandoz Ltd. Polymyxin B conjugates

Also Published As

Publication number Publication date
NO975329L (no) 1997-11-20
PE5398A1 (es) 1998-02-16
CO4700478A1 (es) 1998-12-29
PL323186A1 (en) 1998-03-16
CA2219778A1 (en) 1996-11-28
FI974004A0 (fi) 1997-10-20
EP0830147A1 (en) 1998-03-25
CZ288830B6 (cs) 2001-09-12
HUP9801750A3 (en) 1998-12-28
MX9709003A (es) 1998-03-31
BR9609130A (pt) 1999-02-23
US5691304A (en) 1997-11-25
IL118407A0 (en) 1996-09-12
WO1996037233A1 (en) 1996-11-28
CN1185115A (zh) 1998-06-17
ZA964210B (en) 1997-11-24
TR199701426T1 (xx) 1998-02-21
AU6000796A (en) 1996-12-11
TW426517B (en) 2001-03-21
KR19990021926A (ko) 1999-03-25
SK157997A3 (en) 1998-04-08
RU2164149C2 (ru) 2001-03-20
NZ309764A (en) 1999-04-29
HUP9801750A2 (hu) 1998-11-30
FI974004A (fi) 1997-11-25
NO975329D0 (no) 1997-11-20
CZ372197A3 (cs) 1998-03-18
IL118407A (en) 2000-10-31
JPH11505216A (ja) 1999-05-18
AU711200B2 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
ES2244831T5 (es) Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica
BR0013466A (pt) Polìmeros de absorção de água tendo compostos intersticiais, um processo para sua produção, e seu uso
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
ID29632A (id) Pembuatan bentuk-bentuk dosis larutan bening berair dengan asam-asam empedu
TR199903191T2 (xx) Vorikonazol i�eren ila� form�lasyonlar�.
TNSN01012A1 (fr) Derives amines de dihydro-1, 3,5-triazine et leurs applications en therapeutique
TR199802344A2 (xx) �kame edilmi� imidazolidin t�revleri
NO20024192L (no) Klatratkomplekser dannet ved hjelp av hyaluronsyrederivater og anvendelse derav som farmasöytiske midler
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
AR004488A1 (es) Un conjugado de polimixina, y sales solubles del mismo, proceso para producir dicho conjugado, composicion farmaceutica que incluye dicho conjugado y uso del mismo para la preparacion de medicamentos
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
GT199100051A (es) Composiciones farmaceuticas y metodos para aliviar sintomas de dolores gastrointestinales inducidos por drogas antiinflamatorias no esteroidales
EA200300406A1 (ru) Фармацевтическая композиция дронедарона для парентерального введения
MA25917A1 (fr) Derives d'acides propionique ayant des proprietes activantes de ppar-alpha.
ES2074721T3 (es) Derivados de ciclopentano, procedimientos para su preparacion y su utilizacion farmaceutica.
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
FR2686513B1 (fr) Compositions pharmaceutiques aqueuses de cromoglycate sodique.
PT1102594E (pt) Utilizacao de cloreto de sodio para reduzir a toxicidade gastrointestinal de derivados de camptotecina
WO2002009717A1 (fr) Remedes contre la dyserection contenant des derives de prostaglandine comme principe actif
FR2793685B1 (fr) Compositions pharmaceutiques, destinees a l'administration par voie orale de phloroglucinol et leur preparation
TR199701114T1 (xx) Benzamidlerin n�rodejeneratif hastal�klar�n tedavisinde kullan�lmas�.
CY1106711T1 (el) Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους
ECSP961758A (es) Conjugados de polimixina
BR0015404A (pt) Compostos relacionados com ácido 15-hidroxieicosatetraenóico e métodos de uso
PE20000271A1 (es) Composicion farmaceutica de (1s,4r)-cis-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]-2-ciclopenteno-1-metanol

Legal Events

Date Code Title Description
FB Suspension of granting procedure